Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bethany Hughes

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Biomolecular Screening|May 23, 2007
Quality control procedures for dose-response curve generation using nanoliter dispense technologiesCatherine Quintero, Craig Rosenstein, Bethany Hughes, et al.
Science Signaling|October 28, 2010
PI3K signaling through the dual GTPase-activating protein ARAP3 is essential for developmental angiogenesisLaure Gambardella, Myriam Hemberger, Bethany Hughes, et al.
Scientific Reports|July 28, 2016
Wrinkling Non-Spherical Particles and Its Application in Cell Attachment PromotionMinggan Li, Dehi Joung, Bethany Hughes, et al.
Aging|May 17, 2022
Senescence-associated morphological profiles (SAMPs): an image-based phenotypic profiling method for evaluating the inter and intra model heterogeneity of senescenceRyan Wallis, Deborah Milligan, Bethany Hughes, et al.
Bioorganic & Medicinal Chemistry Letters|October 28, 2008
SAR profiles of spirocyclic nicotinamide derived selective HDAC1/HDAC2 inhibitors (SHI-1:2)Joey L Methot, Christopher L Hamblett, Dawn M Mampreian, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2009
Exploring the pharmacokinetic properties of phosphorus-containing selective HDAC 1 and 2 inhibitors (SHI-1:2)Richard W Heidebrecht, Melissa Chenard, Joshua Close, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2009
Parallel medicinal chemistry approaches to selective HDAC1/HDAC2 inhibitor (SHI-1:2) optimizationSolomon D Kattar, Laura M Surdi, Anna Zabierek, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Delayed and Prolonged Histone Hyperacetylation with a Selective HDAC1/HDAC2 InhibitorJoey L Methot, Dawn Mampreian Hoffman, David J Witter, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2007
The discovery of 6-amino nicotinamides as potent and selective histone deacetylase inhibitorsChristopher L Hamblett, Joey L Methot, Dawn M Mampreian, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2008
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2)Joey L Methot, Prasun K Chakravarty, Melissa Chenard, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Biomolecular Screening|May 23, 2007
Quality control procedures for dose-response curve generation using nanoliter dispense technologiesCatherine Quintero, Craig Rosenstein, Bethany Hughes, et al.
Science Signaling|October 28, 2010
PI3K signaling through the dual GTPase-activating protein ARAP3 is essential for developmental angiogenesisLaure Gambardella, Myriam Hemberger, Bethany Hughes, et al.
Scientific Reports|July 28, 2016
Wrinkling Non-Spherical Particles and Its Application in Cell Attachment PromotionMinggan Li, Dehi Joung, Bethany Hughes, et al.
Aging|May 17, 2022
Senescence-associated morphological profiles (SAMPs): an image-based phenotypic profiling method for evaluating the inter and intra model heterogeneity of senescenceRyan Wallis, Deborah Milligan, Bethany Hughes, et al.
Bioorganic & Medicinal Chemistry Letters|October 28, 2008
SAR profiles of spirocyclic nicotinamide derived selective HDAC1/HDAC2 inhibitors (SHI-1:2)Joey L Methot, Christopher L Hamblett, Dawn M Mampreian, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2009
Exploring the pharmacokinetic properties of phosphorus-containing selective HDAC 1 and 2 inhibitors (SHI-1:2)Richard W Heidebrecht, Melissa Chenard, Joshua Close, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2009
Parallel medicinal chemistry approaches to selective HDAC1/HDAC2 inhibitor (SHI-1:2) optimizationSolomon D Kattar, Laura M Surdi, Anna Zabierek, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Delayed and Prolonged Histone Hyperacetylation with a Selective HDAC1/HDAC2 InhibitorJoey L Methot, Dawn Mampreian Hoffman, David J Witter, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2007
The discovery of 6-amino nicotinamides as potent and selective histone deacetylase inhibitorsChristopher L Hamblett, Joey L Methot, Dawn M Mampreian, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2008
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2)Joey L Methot, Prasun K Chakravarty, Melissa Chenard, et al.
Pageof 2